Nanocap health tech provider Cardiex flat as ‘CONNEQT’ hits Apple Health

The Market Herald
04-01

Cardiex (ASX:CDX) shares have today remained flat on a happier Tuesday ahead of this month’s RBA decision as its CONNEQT cardiovascular health software integrates with the Apple Health application.

Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines from throughout the week. On Spotify, Apple, and more.

Clearly, that news hasn’t been enough to bring a saving dose of liquidity to the stock.

Still, Cardiex customers with a CONNEQT Pulse Monitor – which Cardiex bills as “the world’s most advanced personal arterial health monitor” on its website – can now link that monitor to the Apple Health app.

(One must also have the CONNEQT App to do this, which apparently allows users to boost their “arterial intelligence.” Whatever that means.)

“Once connected, select biomarker results are automatically updated and accessible within the Health Records section of the [Apple] app,” Cardiex wrote on Tuesday.

“This allows users to view their data in one convenient and secure location on their iPhone in addition to the CONNEQT App.”

Why that duplication would be beneficial remains to be seen but the popularity of Apple products could be a boon here for the company. Still, that duplication concern may also be why investors aren’t rushing to snag CDX shares.

There’s also the fact it only applies to US customers using the latest version of iOS.

More market news

Never-ending: And just like that, Trump’s tariffs are back causing more market chaos

Meet GeoGeorge: The HotCopper poster so accurate he got hired as an analyst

“By integrating with Apple Health Records, we are putting important health information at our patients’ fingertips, helping them make informed decisions and manage their health more effectively,” CDX CEO Craig Cooper said.

CDX last traded at 7.5cps.

Join the discussion: See what HotCopper users are saying about Cardiex and be part of the conversations that move the markets.

The material provided in this article is for information only and should not be treated as investment advice. Viewers are encouraged to conduct their own research and consult with a certified financial advisor before making any investment decisions. For full disclaimer information, please click here.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10